Vorapaxar (MK-5348) Mechanism of Action: PAR-1 Inhibition in Platelet Research

Vorapaxar (MK-5348) MOA:Targeting PAR-1/Thrombin Signaling Pathway for Cardiovascular Diseases

🎯 check Vorapaxar (MK-5348) product page

Vorapaxar (MK-5348) is a potent, selective PAR1 antagonist. It affects thrombin/PAR and ERK1/2 signaling pathways by binding to the orthosteric site of PAR1, effectively inhibiting platelet activation and aggregation.

Primary Applications and Mechanism of Action